References
1. Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol . 2017;11(1):55-67. doi: 10.1007/s12105-017-0795-0
2. Urano M, Nakaguro M, Yamamoto Y, et al. Diagnostic significance of HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad histopathologic spectrum. Am J Surg Pathol. 2019;43(7):984-994. doi: 10.1097/PAS.0000000000001258
3. Skalova A, Leivo I, Hellquist H, et al. High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol. 2021;28(3):107-18. doi: 10.1097/PAP.0000000000000298.
4. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31(1):44-57. doi: 10.1097/01.pas.0000213314.74423.d8.